MYC and cancer: LINRIS can induce the K139 ubiquitination of IGF2BP2, thus preventing the degradation of IGF2BP2 by lysosomes, which keeps the content of IGF2BP2 protein at a certain level, and promotes the glycolysis and proliferation of cancer cells through the IGF2BP2/MYC/glycolysis axis [113].